Clinical Trial

EEG Microstates Across At-Risk Mental States

Study acronym: DEMETER
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated September 21, 2023 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to compare subjects with at-risk-mental-state, early psychosis, schizophrenia, depression, and autism spectrum disorders, with healthy controls (N = 21 x 6). The main questions it aims to answer are: * are EEG microstate anomalies associated with diagnosis, clinical and functional prognosis, both in resting conditions and during sleep ? * are EEG microstates anomalies associated with differences in sensorimotor integration, prosodic and conversational, interoceptive, and narrative self ? * an ancillary study will be to see whether in healthy controls EEG microstate properties vary under light hypnosis conditions. Participants will: * undergo deep phenotyping based on psychopathology and neuropsychological assessments * undergo a high-resolution EEG (64 electrodes) with a resting period and a sensorimotor task; and healthy controls will have a light hypnosis period. * undergo a recording of the characteristics of their voice (tone, prosody) * undergo a one-night polysomnography * undergo MRI and biological sampling for multi-omic analyses * undergo a virtual reality experience
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06045897
Lead Sponsor Centre Hospitalier St Anne
Collaborators: Assistance Publique - Hôpitaux de Paris
Conditions Psychotic Disorders, Autism Spectrum Disorder, Major Depressive Disorder, Schizophrenia
Enrollment 126 participants
Start Date 2023-05-30
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2023-09-21